ASGE 2023 Masterclass EUS: Principles, Best Practices & Innovative Paradigms (Virtual) | February 2023-Question and Answer Session Three

Video Transcription

Video Summary

In this video, a panel of experts discusses various topics related to pancreatic diseases. They address concerns about creating a pancreatic duct (PD) leak during an intervention, the use of main duct intraductal papillary mucinous neoplasm (IPMN) and fine-needle aspiration (FNA), and the importance of considering the size and characteristics of cysts before sampling them. The experts also discuss the duration for leaving a stent in pseudocyst drainage and the potential risks of lumen opposing stents. They talk about the use of glucose and carcinoembryonic antigen (CEA) in pancreatic cyst fluid analysis, highlighting that it should be individualized and context-specific. The panelists mention the need for tissue diagnosis and risk stratification for pancreatic neuroendocrine tumors. They talk about guidelines, including the Fukuoka, revised Sendai criteria, and American Gastroenterological Association (AGA) guidelines, and stress the importance of individualized approaches. The experts also address concerns related to performing solid rectal lesion FNA and the use of antibiotics. They discuss the "door knock technique" for increasing cell yield during FNA. Finally, they touch on pancreatic head mass and cyst reporting in endoscopic ultrasound (EUS) reports, emphasizing the need for vasculature and descriptive information. The panel concludes with a discussion on distinguishing between benign and malignant lymph nodes.

Keywords

pancreatic diseases

intraductal papillary mucinous neoplasm

cyst characteristics

pancreatic neuroendocrine tumors

endoscopic ultrasound reports